Advertisment

chronic obstructive pulmonary disease

Lupin Pharma
Drug maker Lupin on Friday said its UK-based unit has received approval to market a generic product indicated for the management of chronic obstructive pulmonary disease (COPD)
Advertisment
Subscribe